北新路橋(002307.SZ):兵團建工集團10%國有股權擬劃轉至兵團國資委
格隆匯1月26日丨北新路橋(002307.SZ)公佈,公司於近日收到控股股東兵團建工集團轉發的《關於劃轉部分國有資本充實社保基金的批覆》,根據兵團行政常務會議審議通過的《兵團劃轉部分國有資本充實社保基金股權劃轉方案》,決定將公司控股股東兵團建工集團10%的國有股權劃轉至兵團國資委,由兵團國資委對劃轉的股權履行出資人職責,並委託新疆生產建設兵團投資有限責任公司對劃入的股權進行專户管理。
本次國有股權劃轉不會導致公司的控股股東和實際控制人發生變化,公司控股股東仍為兵團建工集團,實際控制人仍為新疆生產建設兵團第十一師國資委。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.